Back

Quinidine for Brugada and what to do with Quinidine intolerance.

20 June 2017 (08:30 - 08:52)
Organised by:
Congress Presentation Part of: Medical treatment of channelopathies: effective and safe? Pharmacology EHRA Premium Access EHRA EUROPACE - CARDIOSTIM 2017

About the speaker

Photo
Professor Wataru Shimizu

New Tokyo Hospital, Matsudo (Japan)

3 More presentations in this session

Presentation thumbnail
Ranolazine for LQT3: s treatment that found it's disease?
Professor S. Viskin (Tel Aviv, IL)
Slides Video
Presentation thumbnail
Beta-blockers for LQT3: Contraindicated, acceptable or the drug of choice?
Professor A. Wilde (Amsterdam, NL)
Slides Video
Presentation thumbnail
LQT3 – the role of Ajmaline challenge and of Flecainide and mexilletine in treatment.
Professor P. Schwartz (Milan, IT)

Access the full session

Session thumbnail
Medical treatment of channelopathies: effective and safe?

The Event

Event poster

EHRA EUROPACE - CARDIOSTIM 2017

20 June 2017 08:30 CET
You may be interested in
thumbnail
Congress Presentation
3 September 2019
thumbnail
Congress Session
Challenges in the treatment of myocardial infarction
18 May 2025
thumbnail
Congress Presentation
How to do sodium channel blocker challenge and interpret it
1 April 2025
thumbnail
Congress Presentation
Brugada syndrome unveiled by prosthetic joint infection in an elderly patient
23 June 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources